TAUROSEPT Trademark
Serial Number: 98305772
TAUROSEPT is a trademark filed by
Geistlich Pharma AG
on December 8, 2023. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Leo M. Loughlin Rothwell Figg Ernst & Manbeck, PC
901 New York Avenue, NW
Suite 900 East
Washington, DC 20001
United States
Trademark Details
Filing Date
December 8, 2023
Registration Date
Not Registered
Published for Opposition
August 13, 2024
Goods & Services
Cleansing solution for medical use, namely, catheter lock solution for installation in intra-corporal catheters between treatments for the prevention of catheter sepsis
Filing History
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 10, 2026 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 10, 2026 ASGN
SOU TEAS EXTENSION RECEIVED
Apr 7, 2026 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 6, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 6, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 27, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 26, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 26, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 26, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 3, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 2, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2024 CNSA
ASSIGNED TO EXAMINER
Jul 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2024 NWOS
NEW APPLICATION ENTERED
Dec 8, 2023 NWAP
